IMAGE

Fig. 2

ID
ZDB-IMAGE-240621-12
Source
Figures for Lalonde et al., 2024
Image
Figure Caption

Fig. 2 CreERT2 driver transgenes have predictable and consistent activity in pIGLET14a and pIGLET24b. Comparison of CreERT2-mediated recombination of Tol2-based drl:creERT2 and pIGLET-based lines p14a.drl:creERT2 and p24b.drl:creERT2 by crossing to the loxP reporter hsp70l:Switch and performing a 4-OHT induction series. Transgene and crossing schematics on top, lateral confocal views and anterior to the left. (A and B) Compared to the Tol2-based drl:creERT2 transgenic line, p14a.drl:creERT2 and p24b.drl:creERT2 show accurate lineage contribution dynamics at 56 hpf when treated with 4-OHT at shield stage and 12 ss (A and B). Note that with shield stage 4-OHT induction, drl-expressing cells contributed both to the LPM lineages (heart, pectoral fin, endothelial cells, kidney, mesothelia, blood, pharyngeal arch musculature, and macrophages) and a subset of paraxial mesoderm lineages (median fin fibroblasts and skeletal muscle). With 12 ss 4-OHT induction, LPM lineages are specifically traced with more mosaic labeling of heart, pectoral fin, and kidneys (A and B). Consistent with our p14a.drl:EGFP reporter lines, some neuronal lineage labeling is observed with p14a.drl:creERT2 when induced with 4-OHT at shield stage (yellow asterisk) (B). F2 heterozygous embryos are depicted (B). Scale bar, 200 μm.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci Adv